These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 24330412

  • 1. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients.
    Andrae DA, Patrick DL, Drossman DA, Covington PS.
    Health Qual Life Outcomes; 2013 Dec 13; 11():208. PubMed ID: 24330412
    [Abstract] [Full Text] [Related]

  • 2. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
    Andrae DA, Covington PS, Patrick DL.
    Clin Ther; 2014 May 13; 36(5):663-79. PubMed ID: 24813429
    [Abstract] [Full Text] [Related]

  • 3. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
    Abel JL, Carson RT, Andrae DA.
    Qual Life Res; 2019 Feb 13; 28(2):369-377. PubMed ID: 30267294
    [Abstract] [Full Text] [Related]

  • 4. Irritable bowel syndrome-specific health-related quality of life instrument: development and psychometric evaluation.
    Lee EH, Kwon O, Hahm KB, Kim W, Kim JI, Cheung DY, Kim YJ, Kim JH, Park JJ, Joo MK.
    Health Qual Life Outcomes; 2016 Feb 17; 14():22. PubMed ID: 26882900
    [Abstract] [Full Text] [Related]

  • 5. Patients with irritable bowel syndrome-diarrhea have lower disease-specific quality of life than irritable bowel syndrome-constipation.
    Singh P, Staller K, Barshop K, Dai E, Newman J, Yoon S, Castel S, Kuo B.
    World J Gastroenterol; 2015 Jul 14; 21(26):8103-9. PubMed ID: 26185382
    [Abstract] [Full Text] [Related]

  • 6. Content, face, and construct validity of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) as a measure of bowel-related quality of life in spinal cord injury.
    Abedi A, Kohli P, Montero S, Morales L, Ha N, Abedi A, La Riva A, Ginsberg D, Kreydin E.
    Neurourol Urodyn; 2023 Aug 14; 42(6):1362-1373. PubMed ID: 37166006
    [Abstract] [Full Text] [Related]

  • 7. Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
    Brenner DM, Sayuk GS, Abel JL, Burslem K.
    J Manag Care Spec Pharm; 2021 Apr 14; 27(4):469-477. PubMed ID: 33769858
    [Abstract] [Full Text] [Related]

  • 8. Intestinal symptoms and psychological factors jointly affect quality of life of patients with irritable bowel syndrome with diarrhea.
    Zhu L, Huang D, Shi L, Liang L, Xu T, Chang M, Chen W, Wu D, Zhang F, Fang X.
    Health Qual Life Outcomes; 2015 Apr 18; 13():49. PubMed ID: 25925746
    [Abstract] [Full Text] [Related]

  • 9. The Comparison of WHOQOL-BREF with Disease Specific Heath Related Quality of Life Questionnaire in Irritable Bowel Syndrome.
    Jamali R, Biglari M.
    Acta Med Iran; 2015 Nov 18; 53(11):717-24. PubMed ID: 26786994
    [Abstract] [Full Text] [Related]

  • 10. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
    Huang WW, Zhou FS, Bushnell DM, Diakite C, Yang XH.
    Qual Life Res; 2007 Aug 18; 16(6):991-6. PubMed ID: 17440830
    [Abstract] [Full Text] [Related]

  • 11. Performance of the EQ-5D in patients with irritable bowel syndrome.
    Bushnell DM, Martin ML, Ricci JF, Bracco A.
    Value Health; 2006 Aug 18; 9(2):90-7. PubMed ID: 16626412
    [Abstract] [Full Text] [Related]

  • 12. Discriminant and convergent validity of the GSRS-IBS symptom severity measure for irritable bowel syndrome: A population study.
    Ljótsson B, Jones M, Talley NJ, Kjellström L, Agréus L, Andreasson A.
    United European Gastroenterol J; 2020 Apr 18; 8(3):284-292. PubMed ID: 32213021
    [Abstract] [Full Text] [Related]

  • 13. Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.
    Buono JL, Carson RT, Flores NM.
    Health Qual Life Outcomes; 2017 Feb 14; 15(1):35. PubMed ID: 28196491
    [Abstract] [Full Text] [Related]

  • 14. The Short Health Scale: A Simple, Valid, Reliable, and Responsive Way of Measuring Subjective Health in Patients With Irritable Bowel Syndrome.
    Krarup AL, Peterson E, Ringström G, Törnblom H, Hjortswang H, Simrén M.
    J Clin Gastroenterol; 2015 Aug 14; 49(7):565-70. PubMed ID: 25216385
    [Abstract] [Full Text] [Related]

  • 15. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD, Zhang SS, Hou XH, Li ZH, Chen SN, Feng PM, Yang XN, Li HZ, Wu JQ, Xia PJ, Yang XJ, Zhou HJ, Wang HY, Ai YW, Li K.
    Chin J Integr Med; 2019 Dec 14; 25(12):887-894. PubMed ID: 31292845
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q, Zhang BP, Huang SG, Ouyang WW, Xie JH, Wen ZH, Yang XB.
    Trials; 2018 Jul 11; 19(1):367. PubMed ID: 29996882
    [Abstract] [Full Text] [Related]

  • 17. Further validation of the IBS-QOL: female Mexican IBS patients have poorer quality of life than females from North Carolina.
    Schmulson M, Ortiz O, Mejia-Arangure JM, Hu YB, Morris C, Arcila D, Gutierrez-Reyes G, Bangdiwala S, Drossman DA.
    Dig Dis Sci; 2007 Nov 11; 52(11):2950-5. PubMed ID: 17415635
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD, Lu B, Li ZH, Wei W, Meng LN, Li BS, Tang ZP, Gao R, Wang FY, Lu F, Bian LQ, Zhao YP, Wang P, Zhang YQ.
    Chin J Integr Med; 2018 Sep 11; 24(9):645-652. PubMed ID: 27487786
    [Abstract] [Full Text] [Related]

  • 19. Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.
    Lackner JM, Ma CX, Keefer L, Brenner DM, Gudleski GD, Satchidanand N, Firth R, Sitrin MD, Katz L, Krasner SS, Ballou SK, Naliboff BD, Mayer EA.
    Clin Gastroenterol Hepatol; 2013 Sep 11; 11(9):1147-57. PubMed ID: 23524278
    [Abstract] [Full Text] [Related]

  • 20. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
    Olden KW, Chey WD, Shringarpure R, Paul Nicandro J, Chuang E, Earnest DL.
    Curr Med Res Opin; 2019 Mar 11; 35(3):461-472. PubMed ID: 30293448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.